NCT01540604View on ClinicalTrials.gov

CRD007 for the Treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Symptomatic Carriers

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Duchenne Muscular DystrophyBecker Muscular Dystrophy
Interventions
DRUG

CRD007

Trial Locations (1)

Unknown

Stockholm

All Listed Sponsors
lead

RSPR Pharma AB

INDUSTRY